Quantum.Tech USA 2024

April 24, Cryptography Spotlight, Westin, Downtown | April 25-26, 2024, Main conference, Conrad Hotel

Washington D.C.

Vassilios Pantazopoulos

Head of Scientific Computing & HPC Pfizer

Biotech industry veteran responsible for advancing AI and HPC capabilities used to accelerate the drug discovery process. Vassilios combines a strong science background with over 20 years of hands-on experience engineering world class scientific computing environments for top Pharmaceutical and Biotech organizations. Vassilios started his career as a molecular biologist at Harvard Medical School where he authored several papers in the field of immunology. He quickly transitioned into the field of bioinformatics where he developed numerous applications used in gene discovery before moving on to a start-up biotech company where he led all aspects of the IT infrastructure for a fast-growing company. Today he sets the strategy for HPC, Cloud, and AI to help digitize drug discovery using advanced scientific computing capabilities supporting R&D at Pfizer globally. Vassilios holds a BS in Biology from the University of Massachusetts at Amherst and an MS in Informatics from Northeastern University.

MAIN CONFERENCE AGENDA DAY 1

2:50 PM Have we seen the ‘silver bullet’ moment for quantum computing in life sciences and pharmaceuticals?

  • Is it the pharmaceuticals industry where we will see the big quantum breakthroughs in 2023? 
  • Is QC actually being successfully to advance drug discovery? 
  • Has the hype bubble burst, and if so are pharmaceutical companies having to adjust their expectations? 
  • Is the quantum opportunity being discussed in the boardroom or is it on the periphery? 
  • What R&D breakthroughs have been reached in the past year? 

Check out the incredible speaker line-up to see who will be joining Vassilios.

Download The Latest Agenda